N-[1-[2-(difluoromethoxy)phenyl]pyrrolidin-3-yl]-2-thiomorpholin-3-ylacetamide;dihydrochloride
C17H25Cl2F2N3O2S — CID 119942100
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[2-(difluoromethoxy)phenyl]pyrrolidin-3-yl]-2-thiomorpholin-3-ylacetamide;dihydrochloride
N-[1-[2-(difluoromethoxy)phenyl]pyrrolidin-3-yl]-2-thiomorpholin-3-ylacetamide;dihydrochloride (PubChem CID 119942100) has the molecular formula C17H25Cl2F2N3O2S and a molecular weight of 444.38 g/mol. Its IUPAC name is N-[1-[2-(difluoromethoxy)phenyl]pyrrolidin-3-yl]-2-thiomorpholin-3-ylacetamide;dihydrochloride.
Molecular Properties
| Compound Name | N-[1-[2-(difluoromethoxy)phenyl]pyrrolidin-3-yl]-2-thiomorpholin-3-ylacetamide;dihydrochloride |
|---|---|
| PubChem CID | 119942100 |
| Molecular Formula | C17H25Cl2F2N3O2S |
| Molecular Weight | 444.38 g/mol |
| Exact Mass | 443.10 |
| IUPAC Name | N-[1-[2-(difluoromethoxy)phenyl]pyrrolidin-3-yl]-2-thiomorpholin-3-ylacetamide;dihydrochloride |
| SMILES | Cl.Cl.O=C(CC1CSCCN1)NC1CCN(c2ccccc2OC(F)F)C1 |
| InChI | InChI=1S/C17H23F2N3O2S.2ClH/c18-17(19)24-15-4-2-1-3-14(15)22-7-5-12(10-22)21-16(23)9-13-11-25-8-6-20-13;;/h1-4,12-13,17,20H,5-11H2,(H,21,23);2*1H |
| InChIKey | BWSOLKWJWYNZOV-UHFFFAOYSA-N |
| XLogP | 2.92 |
| TPSA | 53.60 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 444.38 |
| LogP ≤ 5 | 2.92 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 119942100 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.